Coronavirus, Good News

featured image

New Zealand

Eliminated
Frozen food products or freight
Burning cinder
Infection from returners

https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19- novel-coronavirus/covid-19- current-situation/covid-19- current-cases

Cases, 13 7 13 9 12 = 1643

Hospitalised, 1 = 6

Long term resistance

It would be great if,

Antibodies offer “real-world” security

Cellular resistance is lasting

Memory B and T lymphocytes

T assistants, suppressors, killers (cytotoxic)

Even in moderate cases.

New Delhi 24%

Mumbai 24%

Moscow 21.7 %

Stockholm 10 %

New york city 6.9 %

London 17.5 %

UK 6.2 %

Marion Pepper, immunologist, University of Washington

This is precisely what you would expect

All the pieces exist to have a completely protective immune action

Smita Iyer, immunologist, University of California, Davis

This is really appealing

This requires some optimism about herd resistance, and possibly a vaccine

Teacher Danny Altmann, Department of Immunology and Inflammation, Hammersmith Hospital, Imperial College

While this is a little research study, it uses an impressive, real-life, human experiment at a time when we’ve lacked hard-line, official, evidence that neutralising antibodies really provide defense from re-infection

In other words, it’s excellent news

https://www.telegraph.co.uk/global-health/science-and-disease/optimism-covid-19- immunity-climbs-studies-show-antibodies-protect/

Reducing the effects of antibodies associate with defense from SARS-CoV-2 in people throughout a fishery vessel break out with high attack rate

https://www.medrxiv.org/content/101101/2020081320173161 v1

University of Washington IRB

Recognition of immunological correlates would assist research study

Just animal designs to date

Break out of SARS-CoV-2 on a fishing boat

Attack rate on board of 85.2% (104/122 people)

Predeparture serological and viral RT-PCR screening

Repeat screening after go back to coast

Complete information on 120 of the 122 team (9 ladies)

18 excursion, team member needed hospitalization

Mean follow-up of 32.5 days

104 people had a favorable antigen test or seroconverted throughout the follow-up duration

101 established IgG antibodies within 50 days

3 team members seropositive prior to the boat’s departure

None of these team members with antibodies established signs or evaluated antigen favorable

Laboratory research studies likewise revealed their antibodies had neutralising activity

Existence of reducing the effects of antibodies from previous infection was substantially connected with security versus re-infection (p= 0.002).

Robust T cell resistance in convalescent people with asymptomatic or moderate COVID-19

For Infectious Medicine, Stockholm

https://www.biorxiv.org/content/101101/20200629174888 v1

Virus-specific memory T cells have actually been revealed to continue for several years after infection with SARS-CoV-1

Severe stage SARS-CoV-2-specific T cells show high cytotoxic activity

Associated with different scientific markers of illness intensity

SARS-CoV-2-specific T cells were noticeable in antibody-seronegative member of the family

and people with a history of asymptomatic or moderate COVID-19

Cumulative dataset reveals that SARS-CoV-2 generates robust memory T cell reactions

comparable to those observed in the context of effective vaccines

natural direct exposure or infection might avoid frequent episodes of serious COVID-19 likewise in seronegative people.

SARS-CoV-2 causes robust memory T cell actions in antibody-seronegative and antibody-seropositive people with asymptomatic or moderate COVID-19

Practical SARS-CoV-2-specific immune memory continues after moderate COVID-19

https://www.medrxiv.org/content/101101/2020081120171843 v2

Research study was authorized by the University of Washington Institutional Review Board

The just recently emerged SARS-CoV-2 infection is presently triggering a worldwide pandemic and cases continue to increase.

Most of contaminated people experience slightly symptomatic illness

It is unidentified whether this can cause consistent immune memory that may contribute to herd resistance

Longitudinal evaluation

People recuperated from slightly symptomatic COVID-19

To identify if they establish and sustain immunological memory

Recuperated people established SARS-CoV-2-specific IgG antibody

As virus-specific memory B and T cells

Sometimes increased numerically over 3 months following sign start

Memory lymphocytes showed qualities connected with powerful antiviral resistance

Memory T cells produced IFN-γ (interferon Gama) and broadened upon antigen re-encounter

Memory B cells revealed particular antibodies.

https://covid19globalcases.com/coronavirus-good-news/

Comments